Logo image of U6Z.DE

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

FRA:U6Z - Deutsche Boerse Ag - US9168961038 - Common Stock - Currency: EUR

4.588  -0.3 (-6.19%)

Fundamental Rating

3

U6Z gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 62 industry peers in the Oil, Gas & Consumable Fuels industry. While U6Z has a great health rating, there are worries on its profitability. U6Z is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

U6Z had negative earnings in the past year.
U6Z had a negative operating cash flow in the past year.
In the past 5 years U6Z reported 4 times negative net income.
In the past 5 years U6Z reported 4 times negative operating cash flow.
U6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFU6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of U6Z (-3.28%) is worse than 85.71% of its industry peers.
Looking at the Return On Equity, with a value of -3.76%, U6Z is doing worse than 84.13% of the companies in the same industry.
Industry RankSector Rank
ROA -3.28%
ROE -3.76%
ROIC N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
U6Z.DE Yearly ROA, ROE, ROICU6Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

U6Z's Gross Margin of 16.52% is on the low side compared to the rest of the industry. U6Z is outperformed by 77.78% of its industry peers.
U6Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
U6Z.DE Yearly Profit, Operating, Gross MarginsU6Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

8

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
U6Z has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, U6Z has more shares outstanding
There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
U6Z.DE Yearly Shares OutstandingU6Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
U6Z.DE Yearly Total Debt VS Total AssetsU6Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

U6Z has an Altman-Z score of 10.89. This indicates that U6Z is financially healthy and has little risk of bankruptcy at the moment.
U6Z has a better Altman-Z score (10.89) than 98.41% of its industry peers.
There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.89
ROIC/WACCN/A
WACC8.96%
U6Z.DE Yearly LT Debt VS Equity VS FCFU6Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

U6Z has a Current Ratio of 8.05. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.05, U6Z belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
U6Z has a Quick Ratio of 5.46. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.46, U6Z belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.05
Quick Ratio 5.46
U6Z.DE Yearly Current Assets VS Current LiabilitesU6Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -407.50% in the last year.
U6Z shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.86%.
EPS 1Y (TTM)-407.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.67%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15721.3%

3.2 Future

The Earnings Per Share is expected to grow by 52.74% on average over the next years. This is a very strong growth
U6Z is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.57% yearly.
EPS Next Y259.91%
EPS Next 2Y183.9%
EPS Next 3Y74.16%
EPS Next 5Y52.74%
Revenue Next Year239.2%
Revenue Next 2Y113.68%
Revenue Next 3Y74.73%
Revenue Next 5Y50.57%

3.3 Evolution

U6Z.DE Yearly Revenue VS EstimatesU6Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
U6Z.DE Yearly EPS VS EstimatesU6Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.1 -0.1 0.2 -0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

U6Z reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 20.55, U6Z is valued on the expensive side.
73.02% of the companies in the same industry are cheaper than U6Z, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. U6Z is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 20.55
U6Z.DE Price Earnings VS Forward Price EarningsU6Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U6Z.DE Per share dataU6Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

U6Z's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
U6Z's earnings are expected to grow with 74.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y183.9%
EPS Next 3Y74.16%

0

5. Dividend

5.1 Amount

No dividends for U6Z!.
Industry RankSector Rank
Dividend Yield N/A

URANIUM ENERGY CORP

FRA:U6Z (3/7/2025, 7:00:00 PM)

4.588

-0.3 (-6.19%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-05 2024-12-05/bmo
Earnings (Next)03-18 2025-03-18
Inst Owners78.72%
Inst Owner ChangeN/A
Ins Owners1.9%
Ins Owner ChangeN/A
Market Cap1.94B
Analysts80
Price Target10.26 (123.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-467.55%
Min EPS beat(2)-595.05%
Max EPS beat(2)-340.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-99.61%
Min Revenue beat(4)-100%
Max Revenue beat(4)-99.18%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.23%
PT rev (3m)-3.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1801.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)34.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.55
P/S 9408.45
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 9.56
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)0.22
Fwd EY4.87%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS1.69
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE -3.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.52%
FCFM N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 286.86%
Cap/Sales 1530.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.05
Quick Ratio 5.46
Altman-Z 10.89
F-Score2
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)135.76%
Cap/Depr(5y)103.6%
Cap/Sales(3y)511.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-407.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.67%
EPS Next Y259.91%
EPS Next 2Y183.9%
EPS Next 3Y74.16%
EPS Next 5Y52.74%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15721.3%
Revenue Next Year239.2%
Revenue Next 2Y113.68%
Revenue Next 3Y74.73%
Revenue Next 5Y50.57%
EBIT growth 1Y-724.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.87%
EBIT Next 3Y50.45%
EBIT Next 5Y48.91%
FCF growth 1Y-252.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-246.73%
OCF growth 3YN/A
OCF growth 5YN/A